$110.15
13.0913.49%
Last update: Nov 4, 4:50 PM
Zimmer Biomet Holdings Inc
ZBHNYSE
Zimmer Biomet Holdings (ZBH) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Zimmer Biomet Holdings (ZBH) last issued guidance on November 4, 2026 for fiscal year 2026. The company guided earnings per share in the range of $8.5 - $8.6, compared to a consensus EPS estimate of $8.54. Zimmer Biomet Holdings also guided revenue in the range of $8.59B - $8.63B for the period.
Compared to prior guidance, Zimmer Biomet Holdings maintained its EPS outlook from a previous range of $8.47 - $8.59. On the revenue side, the company maintained its revenue forecast from a prior range of $8.55B - $8.64B.
Zimmer Biomet Holdings has issued 18 guidance updates between February 3, 2023 and November 4, 2026. During this period, the company raised its outlook 6 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.88 | $2.01 | $1.86 | $2.39 |
| Actual | $1.90 | $2.07 | $2.09 | $2.42 |
| Surprise | +1.06% | +2.99% | +12.4% | +1.26% |
| Revenue | ||||
| Estimate | $2.04B | $2.13B | $2.07B | $2.21B |
| Actual | $2.06B | $2.18B | $2.09B | $2.24B |
| Surprise | +1.03% | +1.99% | +1.04% | +1.35% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $2.49 | $2.05 | $2.21 |
| Revenue | |||
| Consensus | $2.29B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $1.90 | $1.88 | 1.06 % |
| Q2 | Aug 5, 2026 | $2.07 | $2.01 | 2.99 % |
| Q1 | Apr 28, 2026 | $2.09 | $1.86 | 12.4 % |
| Q4 | Feb 10, 2026 | $2.42 | $2.39 | 1.26 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $2.06B | $2.04B | 1.03 % |
| Q2 | Aug 5, 2026 | $2.18B | $2.13B | 1.99 % |
| Q1 | Apr 28, 2026 | $2.09B | $2.07B | 1.04 % |
| Q4 | Feb 10, 2026 | $2.24B | $2.21B | 1.35 % |
